Redeye remains positive towards Avensia following a Q1 report largely matching our forecasts. We get the impression that a slight market uptick is more likely than a further decline, although the most likely scenario is an unchanged market. We keep our Base Case unchanged and the discount to peers remains significant.
LÄS MER